Lam Research Corp (LRCX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,418,263 | 3,673,366 | 3,687,165 | 4,129,067 | 4,915,172 |
| Marketable Securities | 1,310,872 | 2,116,101 | 2,355,067 | 2,528,841 | 1,795,080 |
| Receivables | 3,026,430 | 2,809,068 | 2,900,362 | 2,317,922 | 2,097,099 |
| Inventories | 2,689,294 | 2,552,032 | 2,348,955 | 2,138,050 | 1,900,024 |
| Other current assets | 3 | 0 | -2 | -3 | 5 |
| TOTAL | $11,652,390 | $11,322,270 | $11,467,950 | $11,274,880 | $10,853,540 |
| Non-Current Assets | |||||
| PPE Net | 1,303,479 | 1,279,836 | 1,208,285 | 1,133,529 | 1,071,499 |
| Intangibles | 1,622,499 | 1,633,254 | 1,641,168 | 1,646,343 | 1,652,968 |
| Other Non-Current Assets | 1,313,787 | 1,049,553 | 1,052,969 | 1,002,253 | 981,045 |
| TOTAL | $4,239,765 | $3,962,643 | $3,902,422 | $3,782,125 | $3,705,512 |
| Total Assets | $15,892,150 | $15,284,910 | $15,370,370 | $15,057,010 | $14,559,050 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 11,349 | 825,434 | 832,847 | 834,138 | 839,877 |
| Accounts payable and accrued liabilities | 829,710 | 760,942 | 722,490 | 662,674 | 592,387 |
| Accrued Expenses | 1,719,483 | 1,292,174 | 1,479,242 | 1,333,568 | 1,272,655 |
| TOTAL | $3,527,867 | $3,612,333 | $3,591,053 | $3,406,868 | $3,162,442 |
| Non-Current Liabilities | |||||
| Long Term Debt | 4,990,333 | 4,991,613 | 4,992,496 | 4,993,495 | 4,970,848 |
| Deferred Revenues | 967,325 | 733,783 | 556,474 | 576,488 | 457,523 |
| Other Non-Current Liabilities | 1,346,764 | 1,306,134 | 1,278,277 | 1,231,153 | 1,242,268 |
| TOTAL | $6,337,097 | $6,297,747 | $6,270,773 | $6,224,648 | $6,213,116 |
| Total Liabilities | $9,864,964 | $9,910,080 | $9,861,826 | $9,631,516 | $9,375,558 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,419,537 | 1,426,193 | 1,429,083 | 1,440,092 | 1,456,252 |
| Common Shares | 143 | 143 | 143 | 145 | 145 |
| Retained earnings | 14,684,910 | 13,725,680 | 12,839,890 | 12,157,150 | 11,520,590 |
| Other shareholders' equity | -63,827 | -60,013 | -50,166 | -76,348 | -83,104 |
| TOTAL | $6,027,188 | $5,374,833 | $5,508,548 | $5,425,492 | $5,183,489 |
| Total Liabilities And Equity | $15,892,152 | $15,284,913 | $15,370,374 | $15,057,008 | $14,559,047 |